“…CIC is involved in many important biochemical pathways, including gluconeogenesis, insulin secretion, inflammation [ 43 , 44 , 45 , 46 ], protein acetylation [ 45 , 47 , 48 ] and innate immune cell function [ 45 ]. Additionally, its activity is decreased during chronic cholestasis [ 49 ], and its inhibition might be useful in nonalcoholic fatty liver disease [ 50 ], as well as in cancer resistance [ 51 , 52 , 53 ] and in apoptosis induction in cancer cells [ 54 ]. The expression of the human CIC (hCIC) is very high in the liver, but this carrier is also expressed in the pancreas and kidney [ 3 ].…”